An interactive demonstration of the Fabless-Bio platform architecture for tissue engineering. This browser-based mockup visualizes how the Detailed Development Strategies Phase could function, specifically demonstrating tissue design.
This is a conceptual demonstration, not production software. It illustrates how fabless-bio designers could specify tissue geometry, generating foundry-agnostic design files that specialized tissue foundries translate into manufacturing instructions. No installation required - it's a client-side HTML interface that runs directly in your browser. Open the file and explore the concept.
The Fabless-Bio model adapts semiconductor industry architecture to tissue engineering, separating design from manufacturing through five phases:
- Concept and Design - Cell source selection and bioprocess planning
- Modeling and Simulation - Virtual prototyping and computational validation
- Detailed Development Strategies - Translation into manufacturable specifications
- Verification and Validation - Design integrity checks and feasibility assessment
- Manufacturing Handoff - Foundry-agnostic Bio-DL files converted via foundry-specific Bio-PDKs
Traditional tissue engineering conflates design and manufacturing - you can't design a bioprinted tissue without knowing the specific printer, bioink rheology, and nozzle parameters. The Fabless-Bio model separates these concerns:
Designers specify biological requirements and geometric intent through standardized formats (Bio-DL).
Foundries translate these specifications using their Biofabrication Process Design Kits (Bio-PDK), which define their specific equipment capabilities, material libraries, resolution limits, and validated protocols.
This demonstration shows how fabless-bio design could work within that framework.
This demonstration helps tissue engineers, foundry operators, investors, and regulators visualize how fabless biofabrication could separate design innovation from manufacturing specialization - mirroring how the semiconductor industry scaled through division of labor rather than vertical integration.
This is a conceptual mockup, not validated production software. It demonstrates interaction patterns and workflow concepts for the proposed Fabless-Bio platform architecture described in the manuscript.
If you reference this demonstration or the Fabless-Bio concept in your work, please cite: [Manuscript under review]
The broader Fabless-Bio platform architecture is detailed in our manuscript "Software Platform Architecture for Fabless Biofabrication," which describes the complete five-phase workflow, Bio-DL/Bio-PDK exchange formats, marketplace infrastructure, and regulatory compliance framework.
Developed by Evolved.Bio to demonstrate the Fabless-Bio platform concept. For questions or collaborations: Alireza Shahin (alireza@itsevolved.com)